SlideShare a Scribd company logo
1 of 11
Vaccine Research International Plc Vaccine SA75 for MRSA NON-CONFIDENTIAL SlideShare April 2010
VRi Vaccine SA75 ,[object Object],[object Object],[object Object],[object Object],[object Object]
VRi History ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
VRi’s Whole-Cell Vaccine approach ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
VRi SA75 Vaccine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
VRi SA75 Vaccine: Toxicology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
VRi SA75 Vaccine: Phase I Clinical Trial ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Phase I Clinical Trial - Monitoring ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Phase I - IgG Immunoblotting Reaction 12/12 0/12 0/12 0.45 9/12 2/12 0/12 0.36 6/12 6/12 0/12 0.15 0/12 5/12 7/12 Placebo Strong Weak None Vaccine Dose (mg)
Longevity of immune response ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Next steps for VRi  ,[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot (17)

Elisa
ElisaElisa
Elisa
 
ELISA
ELISAELISA
ELISA
 
Official Elisa Powerpoint
Official Elisa PowerpointOfficial Elisa Powerpoint
Official Elisa Powerpoint
 
Presentation of elisa test
Presentation of elisa testPresentation of elisa test
Presentation of elisa test
 
Counter immunoelectrophoresis
Counter immunoelectrophoresisCounter immunoelectrophoresis
Counter immunoelectrophoresis
 
Elisa
ElisaElisa
Elisa
 
Complement fixation test (CFT)
Complement fixation test (CFT)Complement fixation test (CFT)
Complement fixation test (CFT)
 
ELISA
ELISAELISA
ELISA
 
ELISA Test: Enzyme-linked Immunosorbent Assay
ELISA Test: Enzyme-linked Immunosorbent AssayELISA Test: Enzyme-linked Immunosorbent Assay
ELISA Test: Enzyme-linked Immunosorbent Assay
 
Ch09 (2)
Ch09 (2)Ch09 (2)
Ch09 (2)
 
Enzyme linked immuno sorbent assay (elisa)
Enzyme linked immuno sorbent assay (elisa)Enzyme linked immuno sorbent assay (elisa)
Enzyme linked immuno sorbent assay (elisa)
 
Elisa
Elisa Elisa
Elisa
 
ELISA
ELISAELISA
ELISA
 
Elisa technique
Elisa techniqueElisa technique
Elisa technique
 
Molecular Biology Techniques (ELISA)
Molecular Biology Techniques (ELISA)Molecular Biology Techniques (ELISA)
Molecular Biology Techniques (ELISA)
 
Sandwich ELISA Protocol
Sandwich ELISA ProtocolSandwich ELISA Protocol
Sandwich ELISA Protocol
 
Sandwich elisa
Sandwich elisaSandwich elisa
Sandwich elisa
 

Viewers also liked

Sensor Interface Descriptors (SID)
Sensor Interface Descriptors (SID)Sensor Interface Descriptors (SID)
Sensor Interface Descriptors (SID)Arne Bröring
 
Sensor Plug & Play with OGC Standards
Sensor Plug & Play with OGC StandardsSensor Plug & Play with OGC Standards
Sensor Plug & Play with OGC StandardsArne Bröring
 
Ness Ppt
Ness PptNess Ppt
Ness PptUmesh
 
When to NoSQL and when to know SQL
When to NoSQL and when to know SQLWhen to NoSQL and when to know SQL
When to NoSQL and when to know SQLSimon Elliston Ball
 

Viewers also liked (6)

ma52009id420
ma52009id420ma52009id420
ma52009id420
 
SID Creator
SID CreatorSID Creator
SID Creator
 
Sensor Interface Descriptors (SID)
Sensor Interface Descriptors (SID)Sensor Interface Descriptors (SID)
Sensor Interface Descriptors (SID)
 
Sensor Plug & Play with OGC Standards
Sensor Plug & Play with OGC StandardsSensor Plug & Play with OGC Standards
Sensor Plug & Play with OGC Standards
 
Ness Ppt
Ness PptNess Ppt
Ness Ppt
 
When to NoSQL and when to know SQL
When to NoSQL and when to know SQLWhen to NoSQL and when to know SQL
When to NoSQL and when to know SQL
 

Similar to V Rifor Slide Share April2010

Intravenous immunoglobulin therapy (IVIG)
Intravenous immunoglobulin therapy (IVIG)Intravenous immunoglobulin therapy (IVIG)
Intravenous immunoglobulin therapy (IVIG)Usama Ragab
 
Laboratory diagnosis of (hiv)
Laboratory diagnosis of  (hiv)Laboratory diagnosis of  (hiv)
Laboratory diagnosis of (hiv)abdulrahman amer
 
Vaccine clinical trial
Vaccine clinical trialVaccine clinical trial
Vaccine clinical trialPiyush Bafna
 
Patient safety goal 4 : Tackling Antimicrobial Resistance
Patient safety goal 4  : Tackling Antimicrobial ResistancePatient safety goal 4  : Tackling Antimicrobial Resistance
Patient safety goal 4 : Tackling Antimicrobial ResistanceHCY 7102
 
Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...
Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...
Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...HoldenYoung3
 
Katie Flanagan - Malaria vaccines current status and challenges
Katie Flanagan - Malaria vaccines current status and challengesKatie Flanagan - Malaria vaccines current status and challenges
Katie Flanagan - Malaria vaccines current status and challengesWAidid
 
STDS- recent diagnosis methods@1223.pptx
STDS- recent diagnosis methods@1223.pptxSTDS- recent diagnosis methods@1223.pptx
STDS- recent diagnosis methods@1223.pptxKamalJungShahi
 
Antibody Testing in Clinical Practice - Indications for Point-of-Care Testing
Antibody Testing in Clinical Practice - Indications for Point-of-Care TestingAntibody Testing in Clinical Practice - Indications for Point-of-Care Testing
Antibody Testing in Clinical Practice - Indications for Point-of-Care TestingBiogal
 
The Evolution of Melaleuca Alternifolia Concentrate/98alive
The Evolution of Melaleuca Alternifolia Concentrate/98aliveThe Evolution of Melaleuca Alternifolia Concentrate/98alive
The Evolution of Melaleuca Alternifolia Concentrate/98aliveSteven Hall
 
OS18 - 6.a.2 Qualitative aspects of the immune responses related to protecti...
OS18 - 6.a.2  Qualitative aspects of the immune responses related to protecti...OS18 - 6.a.2  Qualitative aspects of the immune responses related to protecti...
OS18 - 6.a.2 Qualitative aspects of the immune responses related to protecti...EuFMD
 
Qualitative aspects of the responses related to protection against FMDV chall...
Qualitative aspects of the responses related to protection against FMDV chall...Qualitative aspects of the responses related to protection against FMDV chall...
Qualitative aspects of the responses related to protection against FMDV chall...EuFMD
 
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...Scientific Review
 
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri ...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates  in Maiduguri ...Multidrug Resistance Pattern of Staphylococcus Aureus Isolates  in Maiduguri ...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri ...Scientific Review SR
 

Similar to V Rifor Slide Share April2010 (20)

Intravenous immunoglobulin therapy (IVIG)
Intravenous immunoglobulin therapy (IVIG)Intravenous immunoglobulin therapy (IVIG)
Intravenous immunoglobulin therapy (IVIG)
 
Laboratory diagnosis of (hiv)
Laboratory diagnosis of  (hiv)Laboratory diagnosis of  (hiv)
Laboratory diagnosis of (hiv)
 
Vaccine clinical trial
Vaccine clinical trialVaccine clinical trial
Vaccine clinical trial
 
Intravenous immunoglobulin (IVIG)
Intravenous immunoglobulin (IVIG)Intravenous immunoglobulin (IVIG)
Intravenous immunoglobulin (IVIG)
 
Patient safety goal 4 : Tackling Antimicrobial Resistance
Patient safety goal 4  : Tackling Antimicrobial ResistancePatient safety goal 4  : Tackling Antimicrobial Resistance
Patient safety goal 4 : Tackling Antimicrobial Resistance
 
04 -immunization
04  -immunization04  -immunization
04 -immunization
 
Human parasite vaccines
Human parasite vaccinesHuman parasite vaccines
Human parasite vaccines
 
Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...
Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...
Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...
 
Katie Flanagan - Malaria vaccines current status and challenges
Katie Flanagan - Malaria vaccines current status and challengesKatie Flanagan - Malaria vaccines current status and challenges
Katie Flanagan - Malaria vaccines current status and challenges
 
Sepsis JC.pptx
Sepsis JC.pptxSepsis JC.pptx
Sepsis JC.pptx
 
Cco ias 2013_new_data
Cco ias 2013_new_dataCco ias 2013_new_data
Cco ias 2013_new_data
 
STDS- recent diagnosis methods@1223.pptx
STDS- recent diagnosis methods@1223.pptxSTDS- recent diagnosis methods@1223.pptx
STDS- recent diagnosis methods@1223.pptx
 
Antibody Testing in Clinical Practice - Indications for Point-of-Care Testing
Antibody Testing in Clinical Practice - Indications for Point-of-Care TestingAntibody Testing in Clinical Practice - Indications for Point-of-Care Testing
Antibody Testing in Clinical Practice - Indications for Point-of-Care Testing
 
The Evolution of Melaleuca Alternifolia Concentrate/98alive
The Evolution of Melaleuca Alternifolia Concentrate/98aliveThe Evolution of Melaleuca Alternifolia Concentrate/98alive
The Evolution of Melaleuca Alternifolia Concentrate/98alive
 
HIV Testing
HIV TestingHIV Testing
HIV Testing
 
OS18 - 6.a.2 Qualitative aspects of the immune responses related to protecti...
OS18 - 6.a.2  Qualitative aspects of the immune responses related to protecti...OS18 - 6.a.2  Qualitative aspects of the immune responses related to protecti...
OS18 - 6.a.2 Qualitative aspects of the immune responses related to protecti...
 
Qualitative aspects of the responses related to protection against FMDV chall...
Qualitative aspects of the responses related to protection against FMDV chall...Qualitative aspects of the responses related to protection against FMDV chall...
Qualitative aspects of the responses related to protection against FMDV chall...
 
Update vaccine in primary immune deficiency 2018
Update vaccine in primary immune deficiency 2018Update vaccine in primary immune deficiency 2018
Update vaccine in primary immune deficiency 2018
 
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...
 
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri ...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates  in Maiduguri ...Multidrug Resistance Pattern of Staphylococcus Aureus Isolates  in Maiduguri ...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri ...
 

V Rifor Slide Share April2010

  • 1. Vaccine Research International Plc Vaccine SA75 for MRSA NON-CONFIDENTIAL SlideShare April 2010
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9. Phase I - IgG Immunoblotting Reaction 12/12 0/12 0/12 0.45 9/12 2/12 0/12 0.36 6/12 6/12 0/12 0.15 0/12 5/12 7/12 Placebo Strong Weak None Vaccine Dose (mg)
  • 10.
  • 11.